Delivery Order SPE2DB22D1202-SPE2DB24FVKT3

Award Date 8/13/24
Potential Completion Date 8/14/24
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,119.96 firm fixed-price contract is for the supply of CORTIFOAM 10% AEROSOL 15GM, a medical product, with a performance period through July 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $1,136.83, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CORTIFOAM 10% AEROSOL 15GM, a medical product, and has a completion date of May 5, 2023. The contract is a Delivery Order under a Firm Fixed Price arrangement, with no set-aside designation indicated. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award, valued at $1,140.96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CORTIFOAM 10% AEROSOL 15GM, a medical product, and has a completion date of December 9, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,195.72 firm fixed-price delivery order is for the supply of CORTIFOAM 10% AEROSOL 15GM, a medical product. The contract has an ultimate completion date of July 30, 2024 and was awarded on July 29, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,755.70 firm fixed-price delivery order is for CORTIFOAM 10% AEROSOL 15GM, a pharmaceutical product. The contract has an ultimate completion date of March 21, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,195.72 firm fixed-price delivery order is for the supply of CORTIFOAM 10% AEROSOL 15GM, a medical product. The contract has an ultimate completion date of May 24, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA...
The U.S. government's Defense Logistics Agency (DLA) awarded a delivery order contract worth $5,753.28 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of CORTIFOAM 10% AEROSOL 15GM, a pharmaceutical product, with an ultimate completion date of October 25, 2023. This contract is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026....
Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical firm Cencora Inc., has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide CORTIFOAM 10% AEROSOL 15GM, a pharmaceutical product, with a potential value of $1,673.04. This delivery order has a completion date of February 29, 2024. Amerisourcebergen Drug Corp, acting as the prime contractor, does not have a set-aside designation for this award. In addition to this specific...
This contract award is for the delivery of CORTIFOAM 10% AEROSOL 15GM medical supplies to the Defense Logistics Agency (DLA). The contract, valued at $3,117.12, is a Firm Fixed Price Delivery Order with an ultimate completion date of March 22, 2023. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop...
This federal contract award, with ID SPE2DB22D2206|SPE2DB24FHW48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of CORTIFOAM 10% AEROSOL 15GM, a medical supply item, with a ceiling value of $8,818.18 and a completion date of June 24, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB24FVKT3
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of CORTIFOAM 10% AEROSOL 15GM. The contract has a firm fixed price of $2,502.08 and an ultimate completion date of August 14, 2024. It is not set aside for a specific business category. Amerisourcebergen Drug Corp has been awarded this contract as part of its extensive work providing a wide range of pharmaceutical products and medical supplies to support various government agencies and healthcare programs, including military treatment facilities and veterans' hospitals. The company holds significant Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation for delivering essential medical commodities.

Generated 11/12/24, 9:13 AM